Advertisement

Topics

Potential HHS Pick’s Ties To Pharma Raise Questions About Trump’s Mission To Curb High Prices

09:17 EST 9 Nov 2017 | Kaiser Health News

Alex Azar served at Eli Lilly for a decade, including five years as president of its U.S. Lilly USA, LLC unit.

Original Article: Potential HHS Pick’s Ties To Pharma Raise Questions About Trump’s Mission To Curb High Prices

NEXT ARTICLE

More From BioPortfolio on "Potential HHS Pick’s Ties To Pharma Raise Questions About Trump’s Mission To Curb High Prices"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...